Back
Arbutus Biopharma Stock Price Chart
Sponsored
ABUS
Sponsored
Elon Musk Predicts MAJOR Crisis in Trump's First Year
See Why Investors are Pouring Mountains of Cash into Certain Companies Trump Wants to Solve the Problem.
Sell
29
ABUS
Arbutus Biopharma
Last Price:
$3.18
Seasonality Move:
21.65%
7 Day Trial
ALL ACCESS PASS
$
7
2025 Gold Forecast: A Perfect Storm for Demand
Discover our Gold Price Outlook for 2025--FREE--here-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ABUS is experiencing slight selling pressure.
Arbutus Biopharma Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.36 | Sell |
20-day SMA: | 3.48 | Sell |
50-day SMA: | 3.7 | Sell |
200-day SMA: | 3.44 | Sell |
8-day EMA: | 3.33 | Sell |
20-day EMA: | 3.46 | Sell |
50-day EMA: | 3.61 | Sell |
200-day EMA: | 3.44 | Sell |
Arbutus Biopharma Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.12 | Sell |
Relative Strength Index (14 RSI): | 33.12 | Sell |
Chaikin Money Flow: | -114922 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.32 - 3.64) | Sell |
Bollinger Bands (100): | (3.52 - 4.12) | Sell |
Arbutus Biopharma Technical Analysis
Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Arbutus Biopharma Stock
Is Arbutus Biopharma Stock a Buy?
-
Arbutus Biopharma share price is 3.19 while ABUS 8-day simple moving average is 3.36, which is a Sell signal.
-
The stock price of ABUS is 3.19 while Arbutus Biopharma 20-day SMA is 3.48, which makes it a Sell.
-
Arbutus Biopharma 50-day simple moving average is 3.70 while ABUS share price is 3.19, making it a Sell technically.
-
ABUS stock price is 3.19 and Arbutus Biopharma 200-day simple moving average is 3.44, creating a Sell signal.
ABUS Technical Analysis vs Fundamental Analysis
Sell
29
Arbutus Biopharma (ABUS)
is a Sell
Is Arbutus Biopharma a Buy or a Sell?
-
Arbutus Biopharma stock is rated a SellThe current Arbutus Biopharma [ABUS] share price is $3.19. The Score for ABUS is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
Arbutus Biopharma Stock Info
Market Cap:
604.5M
Price in USD:
3.19
Share Volume:
722.3K
Arbutus Biopharma 52-Week Range
52-Week High:
4.73
52-Week Low:
2.21
Sell
29
Arbutus Biopharma (ABUS)
is a Sell
Arbutus Biopharma Share Price Forecast
-
What is the Arbutus Biopharma stock price today?The Arbutus Biopharma stock price is 3.19 USD today.
-
Will ABUS stock go up or go down?Arbutus Biopharma> share price is forecast to RISE/FALL based on technical indicators
-
Is Arbutus Biopharma overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Arbutus Biopharma is overvalued.
Is Arbutus Biopharma Stock a Buy?
-
Arbutus Biopharma share price is 3.19 while ABUS 8-day exponential moving average is 3.33, which is a Sell signal.
-
The stock price of ABUS is 3.19 while Arbutus Biopharma 20-day EMA is 3.46, which makes it a Sell.
-
Arbutus Biopharma 50-day exponential moving average is 3.61 while ABUS share price is 3.19, making it a Sell technically.
-
ABUS stock price is 3.19 and Arbutus Biopharma 200-day simple moving average is 3.44, creating a Sell signal.
Fundamental Analysis of Arbutus Biopharma
Is Arbutus Biopharma a good investment?
-
Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.06 per share, and an increase next year of $0.04 per share.
Technical Analysis of Arbutus Biopharma
Should I short Arbutus Biopharma stock?
-
ABUS Moving Average Covergence Divergence (MACD) indicator is -0.12, suggesting Arbutus Biopharma is a Sell
-
Arbutus Biopharma Relative Strength Index (RSI) is 33.12, which suggest Arbutus Biopharma is oversold
-
The Bollinger Bands (25) for Arbutus Biopharma is (3.32 - 3.64), which suggest Arbutus Biopharma is a Sell
-
The Bollinger Bands (100) for Arbutus Biopharma is (3.52 - 4.12), which suggest Arbutus Biopharma is a Sell
* Arbutus Biopharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.